| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
3,419 |
2,583 |
$817K |
| J0178 |
Injection, aflibercept, 1 mg |
315 |
222 |
$383K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,964 |
2,160 |
$187K |
| 92134 |
|
4,591 |
3,712 |
$113K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,592 |
1,499 |
$58K |
| 92226 |
|
1,469 |
971 |
$55K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
470 |
460 |
$16K |
| 92202 |
|
1,234 |
1,119 |
$13K |
| 92225 |
|
251 |
135 |
$12K |
| 92250 |
|
248 |
243 |
$10K |
| 92235 |
|
113 |
110 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
128 |
87 |
$9K |
| 76512 |
|
98 |
64 |
$6K |
| 92201 |
|
79 |
64 |
$1K |
| 4040F |
|
2,346 |
1,822 |
$0.11 |
| 1036F |
|
2,099 |
1,644 |
$0.08 |
| G8482 |
Influenza immunization administered or previously received |
1,286 |
1,033 |
$0.06 |
| 4177F |
|
98 |
87 |
$0.05 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
98 |
87 |
$0.05 |
| 2022F |
|
1,533 |
1,131 |
$0.03 |
| 5010F |
|
1,455 |
1,070 |
$0.03 |
| 2021F |
|
1,436 |
1,053 |
$0.03 |